Pregnancy brings about several neurophysiological changes that have a significant impact on how anesthesia is managed. Hormonal shifts, particularly the rise in progesterone and endorphins, influence the nervous system, making women more sensitive to anesthetic drugs. Progesterone, for example, increases the sensitivity of nerve membranes to local anesthetics, meaning lower doses are often needed for procedures like epidurals or spinal anesthesia. Additionally, changes in blood flow to the brain and the permeability of the blood-brain barrier affect how both intravenous and inhaled anesthetics work.
One key change is the reduction in the minimum alveolar concentration (MAC) of volatile anesthetic agents by as much as 30%. This means that a lower concentration of inhaled anesthetics is required to achieve the same effect as in non-pregnant patients. However, this increased sensitivity, combined with the risk of low blood pressure following neuraxial anesthesia, requires careful monitoring and dose adjustments to maintain stable blood pressure during procedures. Ensuring proper dose management minimizes the risk of side effects and helps provide safe and effective anesthesia for pregnant women.
